Polymerization of fibrin: Direct observation and quantification of individual B:b knob-hole interactions.

The polymerization of fibrin occurs primarily through interactions between N-terminal A- and B-knobs, which are exposed by the cleavage of fibrinopeptides A and B, respectively, and between corresponding a- and b-holes in the gamma- and beta-modules. Of the potential knob-hole interactions--A:a, B:b, A:b, and B:a--the first has been shown to be critical for fibrin formation, but the roles of the others have remained elusive. Using laser tweezers-based force spectroscopy, we observed and quantified individual B:b and A:b interactions. Both desA-fibrin with exposed A-knobs and desB-fibrin bearing B-knobs interacted with fragment D from the gammaD364H fibrinogen containing b-holes but no functional a-holes. The strength of single B:b interactions was found to be 15 to 20 pN, approximately 6-fold weaker than A:a interactions. B:b binding was abrogated by B-knob mimetic peptide, the (beta15-66)2 fragment containing 2 B-knobs, and a monoclonal antibody against the beta15-21 sequence. The interaction of desB-fibrin with fragment D containing a- and b-holes produced the same forces that were insensitive to A-knob mimetic peptide, suggesting that B:a interactions were absent. These results directly demonstrate for the first time B:b binding mediated by natural B-knobs exposed in a fibrin monomer.

[1]  L. Betts,et al.  The structure of fibrinogen fragment D with the ‘A’ knob peptide GPRVVE , 2006, Journal of thrombosis and haemostasis : JTH.

[2]  Sergiy Yakovlev,et al.  Structural basis for sequential cleavage of fibrinopeptides upon fibrin assembly. , 2006, Biochemistry.

[3]  R. Doolittle,et al.  Binding of synthetic B knobs to fibrinogen changes the character of fibrin and inhibits its ability to activate tissue plasminogen activator and its destruction by plasmin. , 2006, Biochemistry.

[4]  J. Weisel,et al.  The alphaC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis. , 2005, Blood.

[5]  J. Weisel,et al.  Polymerization of fibrin: specificity, strength, and stability of knob-hole interactions studied at the single-molecule level. , 2005, Blood.

[6]  Rustem I. Litvinov,et al.  Multi-Step Fibrinogen Binding to the Integrin αIIbβ3 Detected Using Force Spectroscopy , 2005 .

[7]  M. Mosesson Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[8]  F. Terasawa,et al.  Functional analysis of recombinant Bβ15C and Bβ15A fibrinogens demonstrates that Bβ15G residue plays important roles in FPB release and in lateral aggregation of protofibrils , 2005, Journal of thrombosis and haemostasis : JTH.

[9]  L. Betts,et al.  BβGlu397 and BβAsp398 but not BβAsp432 are required for B:b interactions , 2004 .

[10]  J. Weisel,et al.  Recombinant BβArg14His fibrinogen implies participation of N-terminus of Bβ chain in desA fibrin polymerization , 2003 .

[11]  L. Betts,et al.  2.8 A crystal structures of recombinant fibrinogen fragment D with and without two peptide ligands: GHRP binding to the "b" site disrupts its nearby calcium-binding site. , 2002, Biochemistry.

[12]  J. Weisel,et al.  Binding strength and activation state of single fibrinogen-integrin pairs on living cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Lord,et al.  Analysis of engineered fibrinogen variants suggests that an additional site mediates platelet aggregation and that "B-b" interactions have a role in protofibril formation. , 2002, Biochemistry.

[14]  L. Medved,et al.  Interaction of fibrin(ogen) with the endothelial cell receptor VE-cadherin: mapping of the receptor-binding site in the NH2-terminal portions of the fibrin beta chains. , 2002, Biochemistry.

[15]  P. Bongrand,et al.  Measuring Receptor/Ligand Interaction at the Single-Bond Level: Experimental and Interpretative Issues , 2002, Annals of Biomedical Engineering.

[16]  M. Huentelman,et al.  Gene Therapy for Cardiovascular Disorders , 2001 .

[17]  R. Doolittle,et al.  Crystal Structure Studies on Fibrinogen and Fibrin , 2001, Annals of the New York Academy of Sciences.

[18]  J. Weisel,et al.  The Structure and Function of the αC Domains of Fibrinogen , 2001 .

[19]  S. Lord,et al.  The Formation of β Fibrin Requires a Functional a Site , 2001 .

[20]  I. Mochalkin,et al.  A model of fibrin formation based on crystal structures of fibrinogen and fibrin fragments complexed with synthetic peptides. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  R. Doolittle,et al.  Conformational changes in fragments D and double-D from human fibrin(ogen) upon binding the peptide ligand Gly-His-Arg-Pro-amide. , 1999, Biochemistry.

[22]  R. Doolittle,et al.  Crystal structure of fragment double-D from human fibrin with two different bound ligands. , 1998, Biochemistry.

[23]  S. Lord,et al.  Severely Impaired Polymerization of Recombinant Fibrinogen γ-364 Asp → His, the Substitution Discovered in a Heterozygous Individual* , 1997, The Journal of Biological Chemistry.

[24]  R. Doolittle,et al.  Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin , 1997, Nature.

[25]  J. Weisel,et al.  The conversion of fibrinogen to fibrin: recombinant fibrinogen typifies plasma fibrinogen. , 1997, Blood.

[26]  A. Ashkin,et al.  Optical trapping and manipulation of neutral particles using lasers. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen , 1997 .

[28]  S. Lord,et al.  Strategy for recombinant multichain protein synthesis: fibrinogen B beta-chain variants as thrombin substrates. , 1996, Biochemistry.

[29]  T. Kamura,et al.  An Abnormal Fibrinogen Fukuoka II (Gly-Bβ 15 → Cys) Characterized by Defective Fibrin Lateral Association and Mixed Disulfide Formation * , 1995, The Journal of Biological Chemistry.

[30]  J. Weisel,et al.  Role of the alpha C domains of fibrin in clot formation. , 1994, Biochemistry.

[31]  J. Weisel,et al.  The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. , 1993, Journal of molecular biology.

[32]  T. Ugarova,et al.  Localization of a fibrin polymerization site complementary to Gly‐His‐Arg sequence , 1993, FEBS letters.

[33]  D. Galanakis,et al.  Unusual A alpha 16Arg-->Cys dysfibrinogenaemic family: absence of normal A alpha-chains in fibrinogen from two of four heterozygous siblings. , 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[34]  T. Ugarova,et al.  Interaction between complementary polymerization sites in the structural D and E domains of human fibrin. , 1992, The Journal of biological chemistry.

[35]  J. Weisel,et al.  Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: clot structure and assembly are kinetically controlled. , 1992, Biophysical journal.

[36]  H. Hirata,et al.  A new congenital abnormal fibrinogen Ise characterized by the replacement of B beta glycine-15 by cysteine. , 1991, Blood.

[37]  B. Kudryk,et al.  Accessibility of epitopes on fibrin clots and fibrinogen gels. , 1991, Blood.

[38]  K. Preissner,et al.  Thrombin-induced fibrinopeptide B release from normal and variant fibrinogens: influence of inhibitors of fibrin polymerization. , 1988, Biochimica et biophysica acta.

[39]  J. Weisel Fibrin assembly. Lateral aggregation and the role of the two pairs of fibrinopeptides. , 1986, Biophysical journal.

[40]  Paul,et al.  Characterization of the kinetic pathway for liberation of fibrinopeptides during assembly of fibrin. , 1985, The Journal of biological chemistry.

[41]  J. Shainoff,et al.  FIBRINOPEPTIDE B IN FIBRIN ASSEMBLY AND METABOLISM: PHYSIOLOGIC SIGNIFICANCE IN DELAYED RELEASE OF THE PEPTIDE * , 1983, Annals of the New York Academy of Sciences.

[42]  R. Doolittle,et al.  SYNTHETIC PEPTIDES MODELED ON FIBRIN POLYMERIZATION SITES , 1983, Annals of the New York Academy of Sciences.

[43]  R. Doolittle Fibrinogen and fibrin. , 1981, Scientific American.

[44]  A. Laudano,et al.  Influence of calcium ion on the binding of fibrin amino terminal peptides to fibrinogen. , 1981, Science.

[45]  A. Laudano,et al.  Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences. , 1980, Biochemistry.

[46]  S. Olexa,et al.  Evidence for four different polymerization sites involved in human fibrin formation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. Hermans,et al.  Assembly of fibrin. A light scattering study. , 1979, The Journal of biological chemistry.

[48]  J. Shainoff,et al.  Fibrinopeptide B and Aggregation of Fibrinogen , 1979, Thrombosis and Haemostasis.

[49]  B. Blombäck,et al.  A two-step fibrinogen–fibrin transition in blood coagulation , 1978, Nature.

[50]  A. Laudano,et al.  Synthetic peptide derivatives that bind to fibrinogen and prevent the polymerization of fibrin monomers. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Hermans,et al.  Role of fibrinopeptide B release: comparison of fibrins produced by thrombin and Ancrod. , 1977, The American journal of physiology.

[52]  J. Soria,et al.  Fibrinogen Troyes - Fibrinogen Metz , 1972, Thrombosis and Haemostasis.

[53]  J. Shainoff,et al.  Studies on a procoagulant fraction of southern copperhead snake venom: the preferential release of fibrinopeptide B. , 1970, The Journal of laboratory and clinical medicine.

[54]  J. Weisel,et al.  Multi-step fibrinogen binding to the integrin (alpha)IIb(beta)3 detected using force spectroscopy. , 2005, Biophysical journal.

[55]  J. Weisel Fibrinogen and fibrin. , 2005, Advances in protein chemistry.

[56]  L. Betts,et al.  B beta Glu397 and B beta Asp398 but not B beta Asp432 are required for "B:b" interactions. , 2004, Biochemistry.

[57]  J. Weisel,et al.  Recombinant BbetaArg14His fibrinogen implies participation of N-terminus of Bbeta chain in desA fibrin polymerization. , 2003, Blood.

[58]  S. Lord,et al.  The formation of beta fibrin requires a functional a site. , 2001, Annals of the New York Academy of Sciences.

[59]  J. Weisel,et al.  The structure and function of the alpha C domains of fibrinogen. , 2001, Annals of the New York Academy of Sciences.

[60]  E. Davie,et al.  Crystal structure of a 30 kDa C-terminal fragment from the gamma chain of human fibrinogen. , 1997, Structure.

[61]  A. Ashkin,et al.  Forces of a single-beam gradient laser trap on a dielectric sphere in the ray optics regime. , 1992, Biophysical journal.

[62]  J. Soria,et al.  Studies on the ultrastructure of fibrin lacking fibrinopeptide B (beta-fibrin). , 1987, Blood.

[63]  B. Kudryk,et al.  Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. , 1984, Molecular immunology.

[64]  A. Henschen,et al.  Novel structure elucidation strategy for genetically abnormal fibrinogens with incomplete fibrinopeptide release as applied to fibrinogen Schwarzach. , 1983, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[65]  A. Bloom Haemostasis and thrombosis , 1981 .

[66]  J. Soria,et al.  [Structural anomaly of Metz fibrinogen, localized on the (A) chain of the molecule]. , 1972, Biochimie.

[67]  J. Soria,et al.  Anomalie de structure du fibrinogène “Metz”, localisée sur la chaîne α (A) de la molécule , 1972 .

[68]  T. Laurent,et al.  On the Significance of the Release of Two Different Peptides from Fibrinogen During Clotting. , 1958 .